Back
Cellectar Biosciences Vs. CNS Pharmaceuticals Industry Stock Comparison
Sell
23
CLRB
Cellectar Biosciences
Last Price:
0.25
Seasonality Move:
-1.67%
Sell
30
CNSP
CNS Pharmaceuticals
Last Price:
0.10
Seasonality Move:
-36.72%
Sell
23
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $0.26. The Score for CLRB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
CNS Pharmaceuticals (CNSP)
is a Sell
Is CNS Pharmaceuticals a Buy, Sell or Hold?
- The current CNS Pharmaceuticals [CNSP] share price is $0.11. The Score for CNSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CNSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $0.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
CNSP Stock Price Chart
What is CNS Pharmaceuticals's stock price today?
-
The CNS Pharmaceuticals share price today is $0.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 5.91 | Sell |
| Chaikin Money Flow: | -6267615 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.11 - 2.03) | Sell |
| Bollinger Bands (100): | (1.63 - 2.29) | Sell |
CNSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 42.06 | Sell |
| Chaikin Money Flow: | 345908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.11 - 0.13) | Sell |
| Bollinger Bands (100): | (-0.01 - 0.37) | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.11 | Sell |
| 20-day SMA: | 1.43 | Sell |
| 50-day SMA: | 1.82 | Sell |
| 200-day SMA: | 2.6 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.34 | Sell |
| 50-day EMA: | 1.69 | Sell |
| 200-day EMA: | 2.29 | Sell |
CNSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.11 | Buy |
| 20-day SMA: | 0.11 | Sell |
| 50-day SMA: | 0.12 | Sell |
| 200-day SMA: | 4.97 | Sell |
| 8-day EMA: | 0.11 | Sell |
| 20-day EMA: | 0.11 | Sell |
| 50-day EMA: | 0.21 | Sell |
| 200-day EMA: | 14.08 | Sell |
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.81 per share.
CNS Pharmaceuticals Earnings Growth & CNSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cellectar Biosciences Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CNS Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||